Align Technology, Inc. (ALGN) Expected to Announce Earnings of $1.16 Per Share

Wall Street analysts expect Align Technology, Inc. (NASDAQ:ALGN) to announce $1.16 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Seven analysts have made estimates for Align Technology’s earnings. The lowest EPS estimate is $1.13 and the highest is $1.24. Align Technology reported earnings of $1.19 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 2.5%. The company is expected to issue its next quarterly earnings report on Tuesday, January 29th.

On average, analysts expect that Align Technology will report full-year earnings of $4.87 per share for the current financial year, with EPS estimates ranging from $4.85 to $4.95. For the next financial year, analysts forecast that the business will post earnings of $5.88 per share, with EPS estimates ranging from $5.65 to $6.10. Zacks’ earnings per share averages are an average based on a survey of analysts that cover Align Technology.

Align Technology (NASDAQ:ALGN) last posted its earnings results on Wednesday, October 24th. The medical equipment provider reported $1.24 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.19 by $0.05. Align Technology had a net margin of 16.89% and a return on equity of 34.09%. The firm had revenue of $505.30 million during the quarter, compared to the consensus estimate of $503.14 million. During the same quarter last year, the firm earned $1.01 EPS. The firm’s revenue for the quarter was up 31.1% on a year-over-year basis.

Several analysts recently weighed in on the stock. Zacks Investment Research downgraded shares of Align Technology from a “hold” rating to a “sell” rating in a report on Monday, October 22nd. Robert W. Baird dropped their target price on shares of Align Technology from $425.00 to $330.00 and set an “outperform” rating for the company in a report on Thursday, October 25th. BidaskClub downgraded shares of Align Technology from a “hold” rating to a “sell” rating in a report on Saturday, October 27th. Credit Suisse Group dropped their target price on shares of Align Technology from $375.00 to $343.00 and set an “outperform” rating for the company in a report on Tuesday, November 20th. Finally, Morgan Stanley dropped their target price on shares of Align Technology from $320.00 to $300.00 and set an “equal weight” rating for the company in a report on Thursday, October 25th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $352.20.

In other Align Technology news, Director Joseph Lacob sold 10,000 shares of the business’s stock in a transaction on Friday, November 30th. The shares were sold at an average price of $231.82, for a total value of $2,318,200.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Sreelakshmi Kolli sold 5,000 shares of the business’s stock in a transaction on Tuesday, November 27th. The stock was sold at an average price of $223.15, for a total transaction of $1,115,750.00. Following the completion of the transaction, the senior vice president now owns 27,180 shares of the company’s stock, valued at approximately $6,065,217. The disclosure for this sale can be found here. In the last 90 days, insiders sold 23,764 shares of company stock valued at $5,427,059. Insiders own 1.40% of the company’s stock.

Several large investors have recently bought and sold shares of ALGN. Sigma Planning Corp grew its stake in shares of Align Technology by 9.8% during the second quarter. Sigma Planning Corp now owns 1,527 shares of the medical equipment provider’s stock worth $522,000 after purchasing an additional 136 shares in the last quarter. Lido Advisors LLC grew its stake in shares of Align Technology by 15.9% during the second quarter. Lido Advisors LLC now owns 1,091 shares of the medical equipment provider’s stock worth $373,000 after purchasing an additional 150 shares in the last quarter. Brighton Jones LLC lifted its position in Align Technology by 5.5% in the second quarter. Brighton Jones LLC now owns 2,898 shares of the medical equipment provider’s stock valued at $992,000 after acquiring an additional 151 shares during the last quarter. HL Financial Services LLC lifted its position in Align Technology by 8.0% in the second quarter. HL Financial Services LLC now owns 2,137 shares of the medical equipment provider’s stock valued at $731,000 after acquiring an additional 158 shares during the last quarter. Finally, State Treasurer State of Michigan lifted its position in Align Technology by 0.9% in the second quarter. State Treasurer State of Michigan now owns 21,400 shares of the medical equipment provider’s stock valued at $7,322,000 after acquiring an additional 200 shares during the last quarter. Institutional investors and hedge funds own 78.03% of the company’s stock.

Align Technology stock traded down $9.06 during trading on Friday, hitting $210.28. The company had a trading volume of 999,188 shares, compared to its average volume of 1,276,854. Align Technology has a 1-year low of $188.57 and a 1-year high of $398.88. The company has a market capitalization of $17.54 billion, a PE ratio of 54.06, a price-to-earnings-growth ratio of 1.91 and a beta of 2.05.

About Align Technology

Align Technology, Inc designs, manufactures, and markets a system of clear aligner therapy, intraoral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services. The company's Clear Aligner segment offers Invisalign Full, a treatment used for a range of malocclusion; Invisalign Teen treatment that addresses orthodontic needs of teenage patients, such as compliance indicators, compensation for tooth eruption, and six free single arch replacement aligners; and Invisalign Assist treatment for anterior alignment and aesthetically-oriented cases.

Recommended Story: Intrinsic Value and Stock Selection

Get a free copy of the Zacks research report on Align Technology (ALGN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply